PAMED NEWS


PAMED the trusted news source for physicians in Pennsylvania.

  • Aug 22, 2025, 09:23 AM

    Late Summer COVID-19 Increase in PA
    A late summer increase in COVID-19 activity in Pennsylvania is occurring. Based on national respiratory virus surveillance, test positivity for COVID-19 in PA has increased sharply in the past three weeks.

  • Aug 14, 2025, 08:25 AM

    August 2025 Board of Trustee Meeting Recap
    Last week, the Pennsylvania Medical Society (PAMED) Board of Trustees convened a hybrid meeting at PAMED headquarters to address key organizational priorities and upcoming initiatives.

  • Aug 7, 2025, 10:04 AM

    FTC Invites Public Comment on Gender-Affirming Care
    On July 28, 2025, the Federal Trade Commission (FTC) announced it is inviting public comment to “better understand how consumers may have been exposed to false or unsupported claims about ‘gender-affirming care’ (GAC), especially as it relates to minors, and to gauge the harms consumers may be experiencing.” The 60-day comment period runs through September 26, 2025.

Recent Articles

  • Aug 22, 2025, 09:23 AM

    Late Summer COVID-19 Increase in PA
    A late summer increase in COVID-19 activity in Pennsylvania is occurring. Based on national respiratory virus surveillance, test positivity for COVID-19 in PA has increased sharply in the past three weeks.

  • Aug 14, 2025, 08:25 AM

    August 2025 Board of Trustee Meeting Recap
    Last week, the Pennsylvania Medical Society (PAMED) Board of Trustees convened a hybrid meeting at PAMED headquarters to address key organizational priorities and upcoming initiatives.

  • Aug 7, 2025, 10:04 AM

    FTC Invites Public Comment on Gender-Affirming Care
    On July 28, 2025, the Federal Trade Commission (FTC) announced it is inviting public comment to “better understand how consumers may have been exposed to false or unsupported claims about ‘gender-affirming care’ (GAC), especially as it relates to minors, and to gauge the harms consumers may be experiencing.” The 60-day comment period runs through September 26, 2025.

  • Aug 7, 2025, 08:33 AM

    FDA Requires Major Changes to Opioid Pain Medication Labeling to Emphasize Risks
    The U.S. Food and Drug Administration is requiring safety labeling changes to all opioid pain medications to better emphasize and explain the risks associated with their long-term use.